Voyager Therapeutics VYGR Balance Sheet (2014-2026)

NASDAQ VYGR
$3.25 -0.15 (-4.41%)
As of: Sep 9, 2026 · 3:59 PM EDT
Reported Financials

Voyager Therapeutics Quarterly Balance Sheet

Periods 48 quarters
Latest Jun 2026

Voyager Therapeutics reported total assets of $197.75M and total liabilities of $43.38M for the quarter ended Jun 2026, down 38.6% year over year. This balance sheet covers 48 quarters of results from Sep 2014 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
111.47M117.43M131.87M78.33M96.86M98.96M268.32M244.29M65.27M68.80M143.08M76.13M112.53M71.37M74.75M43.94M45.12M65.30M43.31M35.77M
Short-term InvestmentsInvestments (Current)
10.02M15.11M34.96M69.73M34.78M19.89M4.99M28.45M187.67M162.07M256.49M294.89M232.84M195.32M161.26M171.65M163.81M131.15M98.17M80.57M
Cash & Current Investments
121.50M132.54M166.83M148.06M131.64M118.85M273.31M272.75M252.94M230.88M399.57M371.02M345.36M266.68M236.02M215.59M208.93M196.45M141.48M116.34M
Receivables - NetNet Receivables
10.00M25.00M80.15M0.84M1.70M15.95M1.50M1.62M1.67M3.19M1.76M1.49M2.93M
Receivables - OtherOther Receivables
1.17M0.73M0.21M0.15M0.23M0.26M0.33M3.35M3.25M3.34M2.62M1.55M3.71M0.68M0.49M0.85M0.85M0.15M0.15M0.22M
Receivables
10.22M25.33M83.49M3.46M3.25M19.67M2.18M2.11M2.52M4.04M1.91M1.65M3.15M
Prepaid Assets
3.54M3.43M3.61M3.42M5.08M5.39M3.98M6.08M5.74M5.32M6.11M7.30M8.41M7.95M7.08M9.77M6.62M4.33M3.86M5.74M
Current Assets
126.20M136.70M170.65M151.63M146.94M124.50M302.62M282.18M261.93M319.68M409.14M381.57M373.44M276.81M245.21M227.89M219.59M202.69M146.98M125.23M
Non-Current Assets
Construction in Progress
Property, Plant & Equipment (Net)PP&E (Net)
22.99M21.92M19.37M19.07M18.08M17.86M17.14M17.24M17.11M16.49M17.38M16.27M15.20M14.31M13.93M13.92M13.29M13.14M12.22M11.19M
Long-Term Investments
1.00M65.70M59.10M46.45M20.08M5.24M30.18M32.48M
Other Non-Current Assets
1.78M1.78M1.78M1.51M1.51M1.51M1.51M1.59M1.59M1.59M2.89M2.87M2.87M2.87M2.87M2.87M5.61M2.74M2.74M2.74M
Non-Current Assets
58.57M57.16M53.53M36.98M35.54M34.86M33.67M33.36M32.73M31.60M60.45M54.66M52.60M116.24M108.03M94.21M68.73M49.59M72.34M72.53M
Assets
184.77M193.85M224.18M188.60M182.48M159.36M336.29M315.54M294.65M351.28M469.59M436.23M426.04M393.05M353.24M322.10M288.31M252.28M219.32M197.75M
Liabilities
Current Liabilities
Accounts Payables
0.59M0.57M1.20M1.22M1.34M2.57M3.70M1.66M3.27M1.60M7.58M2.60M3.16M4.00M2.63M1.80M2.12M5.01M2.72M1.61M
Payables
0.59M0.57M1.20M1.22M1.34M2.57M3.70M1.66M3.27M1.60M7.58M2.60M3.16M4.00M2.63M1.80M2.12M5.01M2.72M1.61M
Accumulated Expenses
11.32M10.95M7.74M7.18M12.53M7.82M7.64M9.06M11.05M16.82M7.59M10.27M11.44M14.17M9.05M12.03M14.95M12.10M6.97M7.95M
Other Accumulated Expenses
5.25M5.57M5.75M2.53M2.75M2.83M2.92M3.01M3.11M3.20M5.94M6.74M6.98M1.20M0.55M0.51M0.63M
Current Leases
5.25M5.57M5.75M2.53M2.75M2.83M2.92M3.01M3.11M3.20M5.94M6.74M6.98M7.23M7.43M7.64M7.85M7.84M7.36M6.88M
Current Deferred Revenue
39.18M33.89M86.99M87.00M56.63M59.38M5.68M31.67M44.26M42.88M51.44M20.52M22.63M24.39M21.09M20.52M10.58M1.59M0.40M0.24M
Total Current Liabilities
26.70M50.98M101.68M97.93M73.24M72.59M19.94M45.40M61.69M64.51M72.55M40.13M44.21M49.79M40.21M41.98M35.49M26.54M17.45M16.68M
Non-Current Liabilities
Non-Current Deffered Revenue
29.64M8.21M8.45M7.88M7.39M6.45M78.87M51.38M37.83M32.36M13.16M19.47M12.15M6.00M4.76M2.61M1.47M
Preferred Stock Liabilities
Operating Leases
40.01M38.61M37.12M21.74M21.02M20.29M19.52M18.73M17.92M17.09M41.99M40.20M38.37M36.50M34.57M32.57M30.52M28.66M27.20M25.69M
Other Non-Current Liabilities
41.01M39.61M38.12M22.74M22.02M21.30M20.52M19.73M18.92M18.09M43.00M41.20M39.37M
Total Non-Current Liabilities
56.34M59.19M110.13M105.81M80.63M79.04M98.81M96.78M99.51M96.87M85.71M59.60M56.36M
Total Liabilities
97.35M98.80M148.25M128.55M102.66M100.34M119.33M116.51M118.43M114.96M128.71M100.81M95.73M93.29M80.54M78.16M68.49M56.20M45.66M43.38M
Shareholder's Equity
Common Equity
87.42M95.06M75.93M60.05M79.82M59.02M216.96M199.03M176.22M236.32M340.89M335.42M330.31M299.76M272.70M243.94M219.82M196.08M173.67M154.38M
Liabilities and Shareholders Equity
184.77M193.85M224.18M188.60M182.48M159.36M336.29M315.54M294.65M351.28M469.59M436.23M426.04M393.05M353.24M322.10M288.31M252.28M219.32M197.75M
Retained Earnings
440.32M442.26M444.54M447.89M450.01M452.71M486.52M490.79M494.00M497.51M613.85M618.54M621.99M626.30M630.05M634.70M638.24M641.89M647.71M653.05M
Treasury Shares
0.13M0.13M